肺泡2型细胞衰老驱动进行性肺纤维化
该研究通过单细胞RNA测序分析9例对照和11例IPF肺组织,发现IPF肺组织AT2细胞呈现细胞衰老转录特征。通过条件性敲除小鼠AT2细胞Sin3a诱导p53依赖性衰老,证实衰老而非AT2细胞丢失促进进行性纤维化,遗传或药理靶向p53激活或衰老可阻断纤维化。
要点
- IPF肺组织AT2细胞具有细胞衰老转录特征。
- AT2细胞衰老足以驱动自发性进行性肺纤维化。
- 靶向p53激活或清除衰老细胞可阻断纤维化。
核心结论
- AT2细胞衰老足以驱动进行性肺纤维化,早期减弱衰老相关通路或清除衰老细胞是预防肺纤维化的有前景治疗策略。
研究设计与样本
- 对9例对照供者近端和远端肺组织及11例IPF纤维化肺组织的上皮细胞进行单细胞RNA测序。
- 构建条件性AT2细胞衰老的新型小鼠模型,通过条件性敲除成年小鼠AT2细胞Sin3a启动p53依赖性细胞衰老。
主要发现
- 从IPF肺组织分离的AT2细胞表现出细胞衰老的特征性转录组特征。
- 条件性敲除AT2细胞Sin3a可启动p53依赖性细胞衰老、AT2细胞耗竭及自发性进行性肺纤维化。
- 衰老而非AT2细胞丢失促进进行性纤维化。
- 遗传或药理干预靶向p53激活或衰老可阻断纤维化发生。
临床怎么用
- 早期减弱衰老相关通路和消除衰老细胞可能成为预防肺纤维化的治疗方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Idiopathic pulmonary fibrosis (IPF) is an insidious and fatal interstitial lung disease associated with declining pulmonary function. Accelerated aging, loss of epithelial progenitor cell function and/or numbers, and cellular senescence are implicated in the pathogenies of IPF.Objectives: We sought to investigate the role of alveolar type 2 (AT2) cellular senescence in initiation and/or progression of pulmonary fibrosis and therapeutic potential of targeting senescence-related pathways and senescent cells.Methods: Epithelial cells of 9 control donor proximal and distal lung tissues and 11 IPF fibrotic lung tissues were profiled by single-cell RNA sequencing to assesses the contribution of epithelial cells to the senescent cell fraction for IPF. A novel mouse model of conditional AT2 cell senescence was generated to study the role of cellular senescence in pulmonary fibrosis.Measurements and Main Results: We show that AT2 cells isolated from IPF lung tissue exhibit characteristic transcriptomic features of cellular senescence. We used conditional loss of Sin3a in adult mouse AT2 cells to initiate a program of p53-dependent cellular senescence, AT2 cell depletion, and spontaneous, progressive pulmonary fibrosis. We establish that senescence rather than loss of AT2 cells promotes progressive fibrosis and show that either genetic or pharmacologic interventions targeting p53 activation or senescence block fibrogenesis.Conclusions: Senescence of AT2 cells is sufficient to drive progressive pulmonary fibrosis. Early attenuation of senescence-related pathways and elimination of senescent cells are promising therapeutic approaches to prevent pulmonary fibrosis.
引用
- Yao C, Guan X, Carraro G, et al. Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021. PMID: 32991815. doi:10.1164/rccm.202004-1274OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。